Efstathia Karagkiozi
Overview
Explore the profile of Efstathia Karagkiozi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
293
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Konstantakopoulou O, Galanis P, Kaitelidou D, Karagkouni I, Korompoki E, Ntaios G, et al.
Stud Health Technol Inform
. 2020 Jul;
272:441-444.
PMID: 32604697
The aim of this study was to assess stroke patients' experiences in regards to hospital stay and during discharge. A cross-sectional study with retrospective data collection was conducted including patients...
12.
Siskou O, Korompoki E, Ntaios G, Tsampalas E, Alexopoulou H, Kalliontzakis I, et al.
Stud Health Technol Inform
. 2020 Jul;
272:421-424.
PMID: 32604692
The aim of this study was to evaluate accessibility of stroke patients to optimal healthcare technology in Greece. Methods: The study population consisted of 313 first ever stroke patients derived...
13.
Ntaios G, Perlepe K, Lambrou D, Sirimarco G, Strambo D, Eskandari A, et al.
Int J Stroke
. 2020 May;
16(1):29-38.
PMID: 32423317
Background And Aims: Only a minority of patients with Embolic Stroke of Undetermined Source (ESUS) receive prolonged cardiac monitoring despite current recommendations. The identification of ESUS patients who have low...
14.
Leventis I, Perlepe K, Sagris D, Sirimarco G, Strambo D, Georgiopoulos G, et al.
Int J Stroke
. 2020 Mar;
15(8):866-871.
PMID: 32122289
Background And Aims: Patients with embolic strokes of undetermined source (ESUS) usually present with mild symptoms. We aimed to compare the baseline characteristics between mild and severe ESUS, identify predictors...
15.
Ntaios G, Perlepe K, Lambrou D, Sirimarco G, Strambo D, Eskandari A, et al.
J Stroke Cerebrovasc Dis
. 2020 Jan;
29(4):104626.
PMID: 31954605
Background: The diagnosis of covert atrial fibrillation (AF) remains a major challenge to guide secondary prevention of patients with embolic stroke of undetermined source (ESUS). Aims: We analyzed consecutive ESUS...
16.
Perlepe K, Sirimarco G, Strambo D, Eskandari A, Karagkiozi E, Vemmou A, et al.
Eur J Intern Med
. 2020 Jan;
75:30-34.
PMID: 31952983
Background And Purpose: We analyzed consecutive patients with embolic stroke of undetermined source (ESUS) from three prospective stroke registries to compare the prognostic performance of different LAD thresholds for the...
17.
Ntaios G, Perlepe K, Lambrou D, Sirimarco G, Strambo D, Eskandari A, et al.
Stroke
. 2019 Dec;
51(2):457-461.
PMID: 31826729
Background and Purpose- The HAVOC score (hypertension, age, valvular heart disease, peripheral vascular disease, obesity, congestive heart failure, coronary artery disease) was proposed for the prediction of atrial fibrillation (AF)...
18.
Ntaios G, Georgiopoulos G, Perlepe K, Sirimarco G, Strambo D, Eskandari A, et al.
Neurology
. 2019 Oct;
93(23):e2094-e2104.
PMID: 31662492
Objective: A tool to stratify the risk of stroke recurrence in patients with embolic stroke of undetermined source (ESUS) could be useful in research and clinical practice. We aimed to...
19.
Ntaios G, Perlepe K, Lambrou D, Sirimarco G, Strambo D, Eskandari A, et al.
J Am Heart Assoc
. 2019 Aug;
8(15):e012858.
PMID: 31364451
Background We aimed to assess the prevalence and degree of overlap of potential embolic sources (PES) in patients with embolic stroke of undetermined source (ESUS). Methods and Results In a...
20.
Paciaroni M, Agnelli G, Caso V, Silvestrelli G, Seiffge D, Engelter S, et al.
Stroke
. 2019 Jun;
50(8):2168-2174.
PMID: 31234756
Background and Purpose- Despite treatment with oral anticoagulants, patients with nonvalvular atrial fibrillation (AF) may experience ischemic cerebrovascular events. The aims of this case-control study in patients with AF were...